# US DOJ Proposes Marijuana Reclassification: Federal Policy Shift > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/marijuana-reclassification-federal-policy-doj-proposes-shift/ > **Published:** 2026-04-25T14:07:12-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:02:16-04:00 > **Clinical Summary:** Explore the DOJ's marijuana reclassification federal policy proposal and its impact on medical research and cannabis regulation in 2026. --- ✦ New CED Clinical Relevance  #82High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic PolicyFederal RegulationMedical CannabisDea Scheduling[Clinical Research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) Why This Matters Reclassifying cannabis from Schedule I to Schedule II would formally acknowledge accepted medical use at the federal level, potentially enabling more rigorous [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) and standardized medical cannabis programs. This shift could reduce regulatory barriers that currently limit physician education, research funding, and patient access to consistent, quality-controlled cannabis medicines. Clinical Summary The DOJ’s proposed reclassification would move cannabis from Schedule I (no accepted medical use) to Schedule II (accepted medical use with high abuse potential), aligning federal policy with evidence supporting therapeutic applications. This change would not legalize recreational use but could facilitate FDA-regulated research, banking services for medical programs, and interstate commerce for medical cannabis. The reclassification process requires public comment periods and DEA final approval, potentially taking months to complete. Dr. Caplan’s Take “This represents the most significant federal policy shift toward evidence-based [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) in decades. While it won’t immediately change what I can prescribe, it should accelerate the research we desperately need to optimize dosing, formulations, and patient selection.” Clinical Perspective 🧠 Clinicians should expect continued state-by-state variation in [medical cannabis access](https://cedclinic.com/medical-marijuana-card-reciprocity/) during this transition period. The reclassification may eventually enable more standardized products and clearer prescribing guidelines, but current medical cannabis recommendations will remain governed by existing state programs. Patients should understand that this policy change, while significant, will not immediately alter their current access or treatment protocols. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20US%20Department%20of%20Justice%20proposes%20marijuana%20reclassification%2C%20potential%20shift%20in%20federal%20stance%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fus-department-of-justice-proposes-marijuana-reclassification-potential-shift-in%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fus-department-of-justice-proposes-marijuana-reclassification-potential-shift-in%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20US%20Department%20of%20Justice%20proposes%20marijuana%20reclassification%2C%20potential%20shift%20in%20federal%20stance%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fus-department-of-justice-proposes-marijuana-reclassification-potential-shift-in%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://www.king5.com/article/news/local/us-department-of-justice-proposes-marijuana-reclassification-potential-shift-federal-stance/281-3da5a423-6a3c-4831-b464-2c4858cdadfc](https://www.king5.com/article/news/local/us-department-of-justice-proposes-marijuana-reclassification-potential-shift-federal-stance/281-3da5a423-6a3c-4831-b464-2c4858cdadfc) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [State of Texas: Marijuana reclassification could expand medical research – KXAN Austin](https://cedclinic.com/marijuana-reclassification-medical-research-texas/) Learn how Texas could benefit from marijuana reclassification with expanded opportunities for [medical research](https://cedclinic.com/cb2-receptor-agonist-parkinsons/) and patient care. [Read More](https://cedclinic.com/marijuana-reclassification-medical-research-texas/) [Federal reclassification of medical marijuana opens new research doors for Colorado scientists](https://cedclinic.com/federal-rescheduling-medical-marijuana-research-access/) Discover how federal reclassification is enabling Colorado researchers to advance medical cannabis studies and [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/). [Explore Research](https://cedclinic.com/federal-rescheduling-medical-marijuana-research-access/) [Changes could be coming to Oklahoma after medical marijuana reclassified – KOCO](https://cedclinic.com/medical-marijuana-reclassification-impacts-oklahoma/) Understand potential regulatory and clinical changes in Oklahoma following the federal marijuana reclassification proposal. [Learn More](https://cedclinic.com/medical-marijuana-reclassification-impacts-oklahoma/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).